Cariprazine as a strategy for augmentation of treatment of major depressive disorder: from pharmacological aspects to clinical practice
Major depressive disorder remains the leading cause of disability worldwide, with up to 33% of patients failing to respond to antidepressant therapy. One promising strategy for the treatment of resistant depression is augmentation of antidepressant therapy with atypical antipsychotics. Cariprazine,...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2025-09-01
|
| Col·lecció: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Matèries: | |
| Accés en línia: | https://www.bekhterevreview.com/jour/article/view/1211 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|